Announcements Trials
Browse Landscape

Phase

Phase 2 53Phase 1/2 7Phase 1 7Phase 3 5Phase 2/3 4

Status

Completed 2Unknown 1Recruiting 1Active not recruiting 1

Sponsor Class

INDUSTRY 8OTHER 5NETWORK 1

Study Type

Interventional 5

Sponsor

Cancer Type

Genitourinary 4

Conditions

Recurrence 1Prostatic Neoplasms 1Prostate Cancer Metastatic 1Metastatic Castration-resistant Prostate Cancer (mCRPC) 1Metastatic Castration-resistant Prostate Cancer 1Adenocarcinoma 1

Interventions

Cisplatin 294Radiotherapy 230Fluorouracil 201Cyclophosphamide 191Capecitabine 182Docetaxel 166Gemcitabine 165Oxaliplatin 162Carboplatin 160Paclitaxel 152Leucovorin 122Drug Therapy 118Dexamethasone 118Doxorubicin 112Etoposide 99Bevacizumab 91Cytarabine 87Vincristine 83Irinotecan 81Rituximab 77Epirubicin 71Prednisone 65Radiosurgery 63Methotrexate 62Surgical Procedures, Operative 61Radiation 60Radiotherapy, Intensity-Modulated 56Neoadjuvant Therapy 53Lenalidomide 52Letrozole 50

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 3 × OTHER × cabazitaxel × Clear all
NCT02044354 2026-04-01

CABA-DOC

Gustave Roussy, Cancer Campus, Grand Paris

Phase 3 Completed
195 enrolled
Genitourinary

Metastatic Castration-resistant Prostate Cancer

NCT01952223 2025-07-30

PEACE2

UNICANCER

Phase 3 Active not recruiting
761 enrolled

Adenocarcinoma, Recurrence

NCT03903835 2025-04-09

ProBio

Karolinska Institutet

Phase 3 Recruiting
750 enrolled
Genitourinary

Metastatic Castration-resistant Prostate Cancer (mCRPC)

NCT02961257 2022-05-12

CABASTY

Association Pour La Recherche des Thérapeutiques Innovantes en Cancérologie

Phase 3 Completed
196 enrolled
Genitourinary

Prostate Cancer Metastatic

NCT01978873 2016-05-04

SensiCab

Örebro University, Sweden

Phase 3 Unknown
400 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡